Showing results (51-60 of 93) with videos related to
Sort By:
Pageof 10
Cardiovascular Diagnosis and Therapy|June 2, 2017
Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burdenYu Kataoka, Jordan Andrews, MyNgan Duong, et al.International Journal of Immunopathology and Pharmacology|February 21, 2003
Steroid and antihistamines modulate RANTES release in cultured peripheral blood mononuclear cells of atopic patientsM. Di Gioacchino, N. Verna, E. Cavallucci, et al.Experimental Dermatology|January 11, 2021
Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor betaTakashi Hashimoto, Leigh A Nattkemper, Hei Sung Kim, et al.Atherosclerosis|January 10, 2014
CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient miceClaudine Tardy, Marine Goffinet, Nadia Boubekeur, et al.The American Journal of Cardiology|March 1, 2008
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemiaJohn F Paolini, Yale B Mitchel, Robert Reyes, et al.Journal of Clinical Pharmacology|February 24, 2006
Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patientsArthur J Bergman, Joanne Burke, Patrick Larson, et al.Allergy and Asthma Proceedings|March 3, 2001
Seasonal variability of non-specific bronchial responsiveness in asthmatic patients with allergy to house dust mitesG Riccioni, F Di Stefano, M De Benedictis, et al.American Heart Journal|September 1, 2020
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditisAllan L Klein, Massimo Imazio, Antonio Brucato, et al.Journal of Clinical Pharmacology|August 20, 2004
Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humansArthur J Bergman, Gail Murphy, Joanne Burke, et al.Cardiology Clinics|November 26, 2008
Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factorsJohn F Paolini, Harold E Bays, Christie M Ballantyne, et al.Pageof 10